AbbVie CDR Valuation
| ABBV Stock | 30.89 0.30 0.98% |
At this time, the firm appears to be fairly valued. AbbVie CDR shows a prevailing Real Value of USD30.88 per share. The current price of the firm is USD30.89. Our model approximates the value of AbbVie CDR from analyzing the firm fundamentals such as price to book of 50.90 X, and Return On Equity of 138.53 as well as examining its technical indicators and probability of bankruptcy.
Price Book 50.9029 | Enterprise Value 639.3 B | Enterprise Value Ebitda 36.2603 | Price Sales 6.5371 | Forward PE 15.674 |
Fairly Valued
Today
Please note that AbbVie CDR's price fluctuation is very steady at this time. Calculation of the real value of AbbVie CDR is based on 3 months time horizon. Increasing AbbVie CDR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AbbVie CDR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AbbVie Stock. However, AbbVie CDR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 30.89 | Real 30.88 | Hype 30.89 | Naive 32.06 |
The intrinsic value of AbbVie CDR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AbbVie CDR's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AbbVie CDR helps investors to forecast how AbbVie stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AbbVie CDR more accurately as focusing exclusively on AbbVie CDR's fundamentals will not take into account other important factors: About AbbVie CDR Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of AbbVie CDR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AbbVie CDR based exclusively on its fundamental and basic technical indicators. By analyzing AbbVie CDR's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of AbbVie CDR's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of AbbVie CDR. We calculate exposure to AbbVie CDR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AbbVie CDR's related companies.Other Information on Investing in AbbVie Stock
AbbVie CDR financial ratios help investors to determine whether AbbVie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbbVie with respect to the benefits of owning AbbVie CDR security.